These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 1412144

  • 21. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK, White HD, Greaves SC.
    N Z Med J; 1990 Feb 14; 103(883):41-3. PubMed ID: 2304688
    [Abstract] [Full Text] [Related]

  • 22. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR, Bacon S.
    Arteriosclerosis; 1989 Feb 14; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [Abstract] [Full Text] [Related]

  • 23. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR, Pula KK, Alton KB, Burrier RE, Watkins RW.
    Metabolism; 2001 Oct 14; 50(10):1234-41. PubMed ID: 11586500
    [Abstract] [Full Text] [Related]

  • 24. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 14; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 25. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT, Nieuwenhuijzen Kruseman AC, Degenaar CP, Wolffenbuttel BH.
    Ned Tijdschr Geneeskd; 1990 Nov 03; 134(44):2142-6. PubMed ID: 2247172
    [Abstract] [Full Text] [Related]

  • 26. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
    Aronson JK, Ng LL.
    Q J Med; 1990 Feb 03; 74(274):111-5. PubMed ID: 2111916
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.
    Illingworth DR, Bacon S.
    Am J Cardiol; 1987 Oct 30; 60(12):33G-42G. PubMed ID: 3314447
    [Abstract] [Full Text] [Related]

  • 30. Reductase inhibitor therapy of hypercholesterolemia.
    Kreisberg RA.
    Trans Am Clin Climatol Assoc; 1991 Oct 30; 102():153-63; discussion 163-5. PubMed ID: 2130558
    [No Abstract] [Full Text] [Related]

  • 31. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW.
    Cardiology; 1990 Oct 30; 77 Suppl 4():14-21. PubMed ID: 2073667
    [Abstract] [Full Text] [Related]

  • 32. Pharmacology and mechanism of action of the new HMG-CoA reductase inhibitors.
    Sirtori CR.
    Pharmacol Res; 1990 Oct 30; 22(5):555-63. PubMed ID: 2126139
    [Abstract] [Full Text] [Related]

  • 33. [Simvastatin].
    Burgmer U, Mohr K.
    Dtsch Med Wochenschr; 1996 Jun 07; 121(23):769-70. PubMed ID: 8646995
    [No Abstract] [Full Text] [Related]

  • 34. Long-term clinical tolerance of lovastatin and simvastatin.
    Bilheimer DW.
    Cardiology; 1990 Jun 07; 77 Suppl 4():58-65. PubMed ID: 2073673
    [Abstract] [Full Text] [Related]

  • 35. Worldwide experience with simvastatin/lovastatin.
    Walker JF.
    Eur Heart J; 1992 Jul 07; 13 Suppl B():21-2. PubMed ID: 1644097
    [No Abstract] [Full Text] [Related]

  • 36. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
    Chao Y, Chen JS, Hunt VM, Kuron GW, Karkas JD, Liou R, Alberts AW.
    Eur J Clin Pharmacol; 1991 Jul 07; 40 Suppl 1():S11-4. PubMed ID: 2044637
    [Abstract] [Full Text] [Related]

  • 37. Lipid lowering drugs in atherosclerosis--the HMG-CoA reductase inhibitors.
    Mantell G.
    Clin Exp Hypertens A; 1989 Jul 07; 11(5-6):927-41. PubMed ID: 2676263
    [Abstract] [Full Text] [Related]

  • 38. HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.
    Kostner GM, Gavish D, Leopold B, Bolzano K, Weintraub MS, Breslow JL.
    Circulation; 1989 Nov 07; 80(5):1313-9. PubMed ID: 2530005
    [Abstract] [Full Text] [Related]

  • 39. Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Garnett WR.
    Am J Health Syst Pharm; 1995 Aug 01; 52(15):1639-45. PubMed ID: 7583826
    [Abstract] [Full Text] [Related]

  • 40. Simvastatin.
    Yeatman E.
    Aust Nurses J; 1991 Jul 01; 21(1):29-30. PubMed ID: 1929970
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.